Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DB-3Q in Medically Refractory Crohn's Disease
NCT07625293Phase 2Recruiting
- Sponsor
- Direct Biologics
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow mesenchymal stem cell derived extracellular vesicles in Crohn's disease (CD), sponsored by Direct Biologics. Started Jun 2026; status: recruiting.
02
Drugs
bone marrow mesenchymal stem cell derived extracellular vesicles
03
Conditions
Crohn's disease (CD)
Beyond the preview
Go deeper on NCT07625293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07625293.